Pharmacokinetics of the Dopamine D2 Agonist S(-)-2-(M-Propyl-M-2-thienylethylamino)-5-hydroxytetralin in Freely Moving Rats

This publication has 18 references indexed in Scilit:

• Reversed-phase liquid chromatographic method with amperometric detection for the determination of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin (N-0437) in human plasma and urine
  Journal of Chromatography B: Biomedical Sciences and Applications, 1990
• The potential antipsychotic activity of the partial dopamine receptor agonist (+) N-0437
  European Journal of Pharmacology, 1990
• The metabolic fate of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in rats after intravenous and oral administration II. Isolation and identification of metabolites
  Xenobiotica, 1990
• The metabolic fate of the dopamine agonist 2-(N-propyl-N-2-thienylethylamino)-5-hydroxytetralin in rats after intravenous and oral administration I. Disposition and metabolic profiling
  Xenobiotica, 1990
• Microdialysis and striatal dopamine release: stereoselective actions of the enantiomers of N-0437
  European Journal of Pharmacology, 1989
• N-0437:a selective D-2 dopamine receptor agonist in in vitro and in vivo models
  European Journal of Pharmacology, 1988
• Separation of N‐0437 enantiomers by RP‐HPLC after pre‐column derivatization with D(+)‐glucuronic acid
  Journal of High Resolution Chromatography, 1987
• In vitro binding of the very potent and selective D-2 dopamine agonist, [3H]N-0437 to calf caudate membranes
  European Journal of Pharmacology, 1987
• The design of resolving agents. Chiral cyclic phosphoric acids
  The Journal of Organic Chemistry, 1985
• In vivo dopamine autoreceptor selectivity appears to be critically dependent upon the aromatic hydroxyl position in a series of N,N-disubstituted 2-aminotetralins
  European Journal of Pharmacology, 1984